Degenerative Disorders Caused by Bcl-2 Deficiency Prevented by Loss of Its BH3-Only Antagonist Bim

Developmental Cell

Volumn 1, Issue 5, 2001, Pages 645-653

  Bouillet, Philippe ^a   Cory, Suzanne ^a   Zhang, Li Chen ^a   Strasser, Andreas ^a   Adams, Jerry M ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; BAK1 PROTEIN, MOUSE; BCL 2 BINDING PROTEIN, BIM; BCL-2-BINDING PROTEIN, BIM; CARRIER PROTEIN; INTERLEUKIN 7; MEMBRANE PROTEIN; ONCOPROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2;

ALLELE; ANIMAL; APOPTOSIS; ARTICLE; C57BL MOUSE; CELL SURVIVAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EAR; GENE DELETION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAIR COLOR; HEMATOPOIESIS; HOMEOSTASIS; KIDNEY; KIDNEY POLYCYSTIC DISEASE; LYMPHOCYTE; MELANOCYTE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SURVIVAL RATE;

ALLELES; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CARRIER PROTEINS; CELL SURVIVAL; EAR; GENE DELETION; HAIR COLOR; HEMATOPOIESIS; HOMEOSTASIS; INTERLEUKIN-7; KIDNEY; LYMPHOCYTES; MELANOCYTES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYCYSTIC KIDNEY DISEASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 0035514046     PISSN: 15345807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1534-5807(01)00083-1     Document Type: Article

References (36)

1. Adams J.M., Cory S. The Bcl-2 protein family. arbiters of cell survival Science. 281:1998;1322-1326.
2. Adams J.M., Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci. 26:2001;61-66.
3. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell. 89:1997;1033-1041.
4. Antonsson B., Montessuit S., Sanchez B., Martinou J.C. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 276:2001;11615-11623.
5. Bouillet P., Metcalf D., Huang D.C.S., Tarlinton D.M., Kay T.W.H., Köntgen F., Adams J.M., Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1999;1735-1738.
6. Bouillet P., Zhang L.C., Huang D.C., Webb G.C., Bottema C.D., Shore P., Eyre H.J., Sutherland G.R., Adams J.M. Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm. Genome. 12:2001;163-168.
7. Chen F., Hersh B.M., Conradt B., Zhou Z., Riemer D., Gruenbaum Y., Horvitz H.R. Translocation of C. elegans CED-4 to nuclear membranes during programmed cell death. Science. 287:2000;1485-1489.
8. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., Korsmeyer S.J. Bcl-2, bcl-x(l) sequester bh3 domain-only molecules preventing bax- and bak-mediated mitochondrial apoptosis. Mol. Cell. 8:2001;705-711.
9. Coles H.S., Burne J.F., Raff M.C. Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development. 118:1993;777-784.
10. Conradt B., Horvitz H.R. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell. 93:1998;519-529.
11. Gross A., McDonnell J.M., Korsmeyer S.J. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1999;1899-1911.
12. Huang D.C.S., Strasser A. BH3-only protein-essential initiators of apoptotic cell death. Cell. 103:2000;839-842.
13. Kamada S., Shimono A., Shinto Y., Tsujimura T., Takahashi T., Noda T., Kitamura Y., Kondoh H., Tsujimoto Y. bcl-2 deficiency in mice leads to pleiotropic abnormalities. accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine Cancer Res. 55:1995;354-359.
14. Koseki C., Herzlinger D., al-Awqati Q. Apoptosis in metanephric development. J. Cell Biol. 119:1992;1327-1333.
15. Lin H.H., Yang T.P., Jiang S.T., Yang H.Y., Tang M.J. Bcl-2 overexpression prevents apoptosis-induced Madin-Darby canine kidney simple epithelial cyst formation. Kidney Int. 55:1999;168-178.
16. Lindsten T., Ross A.J., King A., Zong W., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K.et al. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol. Cell. 6:2000;1389-1399.
17. Ma A., Pena J.C., Chang B., Margosian E., Davidson L., Alt F.W., Thompson C.B. Bclx regulates the survival of double-positive thymocytes. Proc. Natl. Acad. Sci. USA. 92:1995;4763-4767.
18. -/- mice. Cell. 89:1997;1011-1019.
19. Matsuzaki Y., Nakayama K.-I., Nakayama K., Tomita T., Isoda M., Loh D.Y., Nakauchi H. Role of bcl-2 in the development of lymphoid cells from the hematopoietic stem cell. Blood. 89:1997;853-862.
20. Mikhailov V., Mikhailova M., Pulkrabek D.J., Dong Z., Venkatachalam M.A., Saikumar P. Bcl-2 prevents bax oligomerization in the mitochondrial outer membrane. J. Biol. Chem. 276:2001;18361-18374.
21. Murphy K.M., Ranganathan V., Farnsworth M.L., Kavallaris M., Lock R.B. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ. 7:2000;102-111.
22. Nagata M., Nakauchi H., Nakayama K.-I., Nakayama K., Loh D., Watanabe T. Apoptosis during an early stage of nephrogenesis induces renal hypoplasia in bcl-2-deficient mice. Am. J. Pathol. 148:1996;1601-1611.
23. Nakayama K., Nakayama K.-I., Negishi I., Kuida K., Sawa H., Loh D.Y. Targeted disruption of bcl-2αβ in mice. occurrence of gray hair, polycystic kidney disease, and lymphocytopenia Proc. Natl. Acad. Sci. USA. 91:1994;3700-3704.
24. O'Connor L., Strasser A., O'Reilly L.A., Hausmann G., Adams J.M., Cory S., Huang D.C.S. Bim. a novel member of the Bcl-2 family that promotes apoptosis EMBO J. 17:1998;384-395.
25. Parrish J., Metters H., Chen L., Xue D. Demonstration of the in vivo interaction of key cell death regulators by structure-based design of second-site suppressors. Proc. Natl. Acad. Sci. USA. 97:2000;11916-11921.
26. Paus R., Cotsarelis G. The biology of hair follicles. N. Engl. J. Med. 341:1999;491-497.
27. Putcha G.V., Moulder K.L., Golden J.P., Bouillet P., Adams J.M., Strasser A., Johnson E.M.J. Induction of Bim, a proapoptotic BH3-only Bcl-2 family member, is critical for neuronal apoptosis. Neuron. 29:2001;615-628.
28. Ranger A.M., Malynn B.A., Korsmeyer S.J. Mouse models of cell death. Nat. Genet. 28:2001;113-118.
29. Schwenk F., Baron U., Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23:1995;5080-5081.
30. Sorenson C.M., Rogers S.A., Korsmeyer S.J., Hammerman M.R. Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice. Am. J. Physiol. 268:1995;F73-F81.
31. Strasser A., Harris A.W., Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:1991;889-899.
32. Strasser A., O'Connor L., Dixit V.M. Apoptosis signaling. Annu. Rev. Biochem. 69:2000;217-245.
33. Veis D.J., Sorenson C.M., Shutter J.R., Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:1993;229-240.
34. Yamamura K., Kamada S., Ito S., Nakagawa K., Ichihashi M., Tsujimoto Y. Accelerated disappearance of melanocytes in bcl-2-deficient mice. Cancer Res. 56:1996;3546-3550.
35. Zheng T.S. Death by design. the big debut of small molecules Nat. Cell Biol. 3:2001;E43-E46.
36. Zong W.X., Lindsten T., Ross A.J., MacGregor G.R., Thompson C.B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15:2001;1481-1486.